Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1985 1
1991 1
1998 1
1999 1
2009 2
2010 3
2011 1
2012 3
2013 4
2014 6
2015 6
2016 1
2017 2
2018 2
2019 5
2020 8
2021 6
2022 4
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Nephropathy in Diabetes.
Merker L, Bautsch BW, Ebert T, Guthoff M, Isermann B. Merker L, et al. Exp Clin Endocrinol Diabetes. 2021 Aug;129(S 01):S60-S63. doi: 10.1055/a-1284-6211. Epub 2021 Jan 4. Exp Clin Endocrinol Diabetes. 2021. PMID: 33395705 No abstract available.
Nephropathy in Diabetes.
Merker L, Ebert T, Guthoff M, Isermann B. Merker L, et al. Exp Clin Endocrinol Diabetes. 2023 Feb;131(1-02):61-65. doi: 10.1055/a-1946-3783. Epub 2023 Jan 23. Exp Clin Endocrinol Diabetes. 2023. PMID: 36690021 No abstract available.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators. Pfeffer MA, et al. N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30. N Engl J Med. 2009. PMID: 19880844 Free article. Clinical Trial.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
[Nephropathy in diabetes].
Merker L. Merker L. MMW Fortschr Med. 2021 Apr;163(8):48-51. doi: 10.1007/s15006-021-9782-1. MMW Fortschr Med. 2021. PMID: 33904093 Review. German. No abstract available.
Sophisticated CRISPR/Cas tools for fine-tuning plant performance.
Capdeville N, Merker L, Schindele P, Puchta H. Capdeville N, et al. Among authors: merker l. J Plant Physiol. 2021 Feb;257:153332. doi: 10.1016/j.jplph.2020.153332. Epub 2020 Dec 15. J Plant Physiol. 2021. PMID: 33383400 Review.
65 results